Your browser doesn't support javascript.
loading
Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN).
Liu, Jin; Hu, Xiaoxia; Jia, Yanchun; Lu, Jin; Lee, Jae Hoon; Kim, Kihyun; Chen, Wenming; Liu, Aijun; Liu, Yang; Chen, Qi; Zhang, Chunyang; Suh, Cheolwon; Kim, Min Kyoung; Zhou, Fan; Chng, Wee Joo; Kumar, Shaji K; Durie, Brian; Hou, Jian; Fu, Weijun; Du, Juan.
Afiliação
  • Liu J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China.
  • Hu X; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Jia Y; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China.
  • Lu J; Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China.
  • Lee JH; Incheon Regional Cancer Center, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Chen W; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Liu A; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Liu Y; Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China.
  • Chen Q; Department of Health Statistics, Second Military Medical University, Shanghai, China.
  • Zhang C; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China.
  • Suh C; School of Medicine, University of Maryland Baltimore, Baltimore, Maryland, USA.
  • Kim MK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Zhou F; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Republic of Korea.
  • Chng WJ; Department of Hematology & Oncology, Jingan District Zhabei Central Hospital Shanghai, Shanghai, China.
  • Kumar SK; Department of Hematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore.
  • Durie B; Cancer Science Institute of Singapore, Singapore, Singapore.
  • Hou J; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Fu W; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Du J; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Leukemia ; 35(6): 1797-1802, 2021 06.
Article em En | MEDLINE | ID: mdl-33082513
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina D / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina D / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido